Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Haematologica|June 20, 2015
Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experiencePaolo Strati, Samih H Nasr, Nelson Leung, et al.
Blood|March 16, 2013
Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL)Tait D Shanafelt, Alan G Ramsay, Clive S Zent, et al.
Experimental Hematology|May 7, 2022
Serum B-Cell maturation antigen is an independent prognostic marker in previously untreated chronic lymphocytic leukemiaCamilia M Soof, Tanya M Spektor, Sameer A Parikh, et al.
Leukemia & Lymphoma|August 5, 2011
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemiaClive S Zent, Brian J Smith, Zuhair K Ballas, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 1, 2015
Impact of Alemtuzumab Therapy and Route of Administration in T-Prolymphocytic Leukemia: A Single-Center ExperienceMoussab Damlaj, Nanna H Sulai, Jennifer L Oliveira, et al.
Cancer Genetics and Cytogenetics|June 2, 2006
Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemiaStephanie R Fink, Stephanie A Smoley, Kimberly J Stockero, et al.
Leukemia & Lymphoma|December 12, 2022
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selectionKurt S Bantilan, Neil E Kay, Sameer A Parikh, et al.
British Journal of Haematology|April 4, 2008
Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemiaShanique Palmer, Curtis A Hanson, Clive S Zent, et al.
British Journal of Haematology|October 4, 2007
Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemiaKami Maddocks-Christianson, Susan L Slager, Clive S Zent, et al.
British Journal of Haematology|April 7, 2009
Risk of non-Hodgkin lymphoma in association with germline variation in complement genesJames R Cerhan, Anne J Novak, Zachary S Fredericksen, et al.
Pageof 20